Quick Answer
BIO-PATH HOLDINGS, INC. reported Research And Development Expense of $7.30 million for the year ending 2024.
- BIO-PATH HOLDINGS, INC. showed a decrease of -37.2% in Research And Development Expense from 2023 to 2024.
- This data is from BIO-PATH HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2012 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $401.1 thousand | Q2 2013: $156.0 thousand | Q3 2013: $568.6 thousand | Q1 2014: $107.6 thousand | Q2 2014: $517.0 thousand | Q3 2014: $424.5 thousand | Q1 2015: $593.0 thousand | Q2 2015: $564.0 thousand | Q3 2015: $992.0 thousand | Q1 2016: $1.02 million | Q2 2016: $1.19 million | Q3 2016: $2.31 million | Q1 2017: $1.03 million | Q2 2017: $1.48 million | Q3 2017: $1.58 million | Q1 2018: $932.0 thousand | Q2 2018: $827.0 thousand | Q3 2018: $2.34 million | Q1 2019: $398.0 thousand | Q2 2019: $1.52 million | Q3 2019: $1.38 million | Q1 2020: $2.01 million | Q2 2020: $1.03 million | Q3 2020: $2.00 million | Q1 2021: $1.26 million | Q2 2021: $760.0 thousand | Q3 2021: $981.0 thousand | Q1 2022: $2.10 million | Q2 2022: $1.85 million | Q3 2022: $2.35 million | Q1 2023: $3.99 million | Q2 2023: $3.05 million | Q3 2023: $2.29 million | Q1 2024: $2.29 million | Q2 2024: $1.87 million | Q3 2024: $1.32 million | Q1 2025: $1.98 million | Q2 2025: $4.05 million | Q3 2025: $275.0 thousand.
- Over the full 14 years of available data (2012 to 2024), BIO-PATH HOLDINGS, INC.'s Research And Development Expense has grown by 544.0%.
- Historical annual values: Fiscal year 2024: $7.30 million | Fiscal year 2023: $11.61 million | Fiscal year 2022: $9.17 million | Fiscal year 2021: $5.91 million | Fiscal year 2020: $6.58 million | Fiscal year 2019: $4.59 million | Fiscal year 2018: $4.60 million | Fiscal year 2017: $5.48 million | Fiscal year 2016: $5.47 million | Fiscal year 2015: $3.02 million | Fiscal year 2014: $1.63 million | Fiscal year 2014: $1.63 million | Fiscal year 2013: $1.52 million | Fiscal year 2012: $1.13 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: